ChAdOx1 and MVA based vaccine candidates against MERS-CoV elicit neutralising antibodies and cellular immune responses in mice

ChAdOx1 and MVA based vaccine candidates against MERS-CoV elicit neutralising antibodies and cellular immune responses in mice

The Middle East respiratory syndrome coronavirus (MERS-CoV) has infected more than 1900 humans, since 2012. The syndrome ranges from asymptomatic and mild cases to severe pneumonia and death. The virus is believed to be circulating in dromedary camels without notable symptoms since the 1980s. Theref...

Full description

Bibliographic Details
Main Authors: Alharbi, N, Regalado, E, Thompson, C, Kupke, A, Wells, D, Sloan, M, Grehan, K, Temperton, N, Lambe, T, Warimwe, G, Becker, S, Hill, A, Gilbert, S
Format: Journal article
Published: Elsevier 2017

Similar Items

Similar Items